Psychiatr. pro Praxi, 2010; 11(3): 99-102

Pharmacotherapy of dissociative disorders

MUDr.Bc.Aleš Grambal1,2, MUDr.Zuzana Grambalová3, MUDr.PhDr.Petr Pastucha1, doc.MUDr.Ján Praško, CSc.1,4,5
1 Klinika psychiatrie FN Olomouc, UP v Olomouci
2 Radiologická klinika FN Olomouc
3 Neurologická klinika FN Olomouc
4 Psychiatrické centrum Praha
5 Centrum neuropsychiatrických studií Praha

Dissociative disorders have heterogenic and mostly dramatic manifestation. Dissociative states are frequently present in patiens suffering

from other psychiatric disorders. Usually we can find a context between dissociative disorder and traumatic experience in the patients

history. The psychogenic etiology is evident. The promptitude for reaction to stress with disociation begans in the disharmonious childhood.

Several years persisted disorder becomes chronic and resisted to treatment. The specific therapy of the disociative disorders does

not exist. The first choice of the therapies are psychoterapautic interventions. Pharmacological methods are advised to treat attendant

psychiatric symptoms. The effect of the transcranial magnetic stimulation is investigated.

Keywords: dissociative disorders, course, comorbidity, pharmacotherapy

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Grambal A, Grambalová Z, Pastucha P, Praško J. Pharmacotherapy of dissociative disorders. Psychiatr. praxi. 2010;11(3):99-102.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mulder RT, Beautrais AL, Joyce PR, et al. Relationship between dissociation, childhood sexual abuse, childhood physical abuse, and mental illness in a general population sample. Am J Psychiatry 1998; 155: 806-811. Go to PubMed...
    2. Putnam FW, Guroff JJ, et al. The clinical phenomenology of multiple personality disorder. Review of 100 recent cases. J Clin Psychiatr 1986; 47: 285-293.
    3. Pastucha P, Prasko J, Grambal A, et al. Dissociative disorder and dissociation - comparison with healthy controls. Neuro Endocrinol Lett. 2009; 30(6): 769-773. Go to PubMed...
    4. Giese AA, Thomas MR, Dubovsky SL. Dissociative symptoms in psychotic mood disorders: an example of symptom nonspecificity. Psychiatry 1997; 60: 60-66. Go to original source... Go to PubMed...
    5. Benbadis SR, Hauser WA. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure 2000; 9: 280-281. Go to original source... Go to PubMed...
    6. Bowman ES. Psychopathology and outcome in pseudoseizures. In: Ettinger AB, Kanner AM (eds). Psychiatric issues in epilepsy. Lippincott Williams a Wilkins, Philadelphia, 2001.
    7. Maldonado JR, Butler LD, Spiegel D. Treatment of dissociative disorders. In Treatments That Work. Edited by Nathan P, Gorman JM. New York, Oxford University Press, 2000: 463-493.
    8. Maldonado JR, Butler LD, Spiegel D. Treatments for dissociative disorders. In A Guide To Treatments That Work, 2nd Edition. New York: Oxford University Press 2002. International Society for the Study of Dissociation (ISSD), Guidelines for the Evaluation and Treatment of Dissociative Symptoms in Children and Adolescents, Journal of Trauma & Dissociation, 2004, 5(3), http://www.haworthpress.com/web/JTD. Go to original source...
    9. Ilechukwu ST, Henry T. Amytal interview using intravenous lorazepam in a patient with dissociative fugue. Gen Hosp Psychiatry 2006; 28: 544-545. Go to original source... Go to PubMed...
    10. Perry JC, Jacobs D. Overview: clinical applications of the Amytal interview in psychiatric emergency settings. Am J Psychiatry 1982; 139: 552-559. Go to original source... Go to PubMed...
    11. Raszka M, Praško J. Depersonalizace a derealizace - současné nálezy. Cesk Slov Neurol N 2008; 71/104 (3).
    12. Philipsen A, Schmahl C, Lieb K. Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder. Pharmacopsychiatry 2004; 37(5): 196-199. Go to original source... Go to PubMed...
    13. Aybek S, Kanaan RA, David AS. The neuropsychiatry of conversion disorder. Curr. Opin. Psychiatry 2008; 21: 275-280. Go to original source... Go to PubMed...
    14. Chastan N, Parain D, Vérin E, et al. Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry 2009; 80: 94. Go to original source... Go to PubMed...
    15. Praško J, Pastucha P, Raszka M. Disociativní křeče. Česk Slov Neurol N 2009; 72, 105(2).
    16. Ettinger AE, Devinsky O, Weisbrot DM, et al. A comprehensive profile of clinical, psychiatric, and psychosocial characteristics of patients with psychogenic nonepileptic seizures. Epilepsia 1999; 40: 1292-1298. Go to original source... Go to PubMed...
    17. Aboukasm A, Mahr G, Gahry BR, et al. Retrospective analysis of the effects of psychotherapeutic interventions on outcomes of psychogenic nonepileptic seizures. Epilepsia 1998; 39: 470-473. Go to original source... Go to PubMed...
    18. Barkin R, Braun BG, Kluft RP. The dilemma of drug therapy for multiple personality disorder. In Treatment of Multiple Personality Disorder. Edited by Braun BG. Washington, DC, American Psychiatric Press, 1986: 107-132. Go to original source...
    19. Mesulam MM. Dissociative states with abnormal temporal lobe EEG: multiple personality and the illusion of possession. Arch Neurol 1981; 38: 178-181. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.